Literature DB >> 8612998

Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis.

M Mourelle1, F Guarner, J R Malagelada.   

Abstract

BACKGROUND & AIMS: Polyunsaturated phosphatidylcholine stimulates collagen breakdown in experimental models of liver cirrhosis. Bowel strictures are characterized by excess deposition of collagen in the intestinal wall. The aim of this study was to investigate the effect of polyunsaturated phosphatidylcholine in the prevention of bowel strictures.
METHODS: Colitis was induced by trinitrobenzenesulfonic acid. On day 21, the presence of strictures was assessed in control rats, rats with colitis, and phosphatidylcholine-fed (100 mg/day) rats with colitis. Furthermore, serum transforming growth factor beta1, collagen deposition, and collagenase activity in colonic tissue were measured in all groups.
RESULTS: None of the control rats but 12 of 16 rats with colitis developed colonic strictures. In contrast, only 2 of 15 phosphatidylcholine-fed rats with colitis showed strictures. Collagen content was much higher in rats with colitis than in phosphatidylcholine-fed rats with colitis and control rats. Phosphatidylcholine-fed rats showed significantly higher collagenase activity in colonic tissue than rats with colitis and control rats. In an ancillary study, free linoleic acid-fed rats showed no differences when compared with rats with colitis. Stimulation of transforming growth factor beta1 was similar in all rats with colitis.
CONCLUSIONS: Oral supplementation with polyunsaturated phosphatidylcholine prevents the accumulation of collagen in inflamed intestinal tissue and the formation of strictures. This effect is associated with an enhanced collagen catabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612998     DOI: 10.1053/gast.1996.v110.pm8612998

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?

Authors:  H Allgayer; P Böhne; W Kruis
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

Review 2.  Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?

Authors:  P R Gibson; J G Muir
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

4.  Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis.

Authors:  W Stremmel; U Merle; A Zahn; F Autschbach; U Hinz; R Ehehalt
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

5.  Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis.

Authors:  I J J Claes; Sarah Lebeer; C Shen; T L A Verhoeven; E Dilissen; G De Hertogh; D M A Bullens; J L Ceuppens; G Van Assche; S Vermeire; P Rutgeerts; J Vanderleyden; S C J De Keersmaecker
Journal:  Clin Exp Immunol       Date:  2010-08-20       Impact factor: 4.330

6.  Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats.

Authors:  E Vaquero; X Molero; X Tian; A Salas; J R Malagelada
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

Review 7.  Regulation of T cell signalling by membrane lipids.

Authors:  Wei Wu; Xiaoshan Shi; Chenqi Xu
Journal:  Nat Rev Immunol       Date:  2016-10-10       Impact factor: 53.106

8.  Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid.

Authors:  N Nieto; M I Fernandez; M I Torres; A Ríos; M D Suarez; A Gil
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

9.  Anti-inflammatory effects of phosphatidylcholine.

Authors:  Irina Treede; Annika Braun; Richard Sparla; Mark Kühnel; Thomas Giese; Jerrold R Turner; Elsa Anes; Hasan Kulaksiz; Joachim Füllekrug; Wolfgang Stremmel; Gareth Griffiths; Robert Ehehalt
Journal:  J Biol Chem       Date:  2007-07-18       Impact factor: 5.157

10.  Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.

Authors:  Jessica Bauer; Gerhard Liebisch; Claudia Hofmann; Christian Huy; Gerd Schmitz; Florian Obermeier; Jürgen Bock
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.